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Oral Prion Disease Pathogenesis Is
Impeded in the Speciﬁc Absence of
CXCR5-Expressing Dendritic Cells
Barry M. Bradford,a Boris Reizis,b Neil A. Mabbotta
The Roslin Institute and Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Easter Bush, United
Kingdoma; Department of Pathology, New York University Langone Medical Center, New York, New York, USAb
ABSTRACT After oral exposure, the early replication of certain prion strains upon
stromal cell-derived follicular dendritic cells (FDC) in the Peyer’s patches in the small
intestine is essential for the efﬁcient spread of disease to the brain. However, little is
known of how prions are initially conveyed from the gut lumen to establish infec-
tion on FDC. Our previous data suggest that mononuclear phagocytes such as CD11c
conventional dendritic cells play an important role in the initial propagation of prions
from the gut lumen into Peyer’s patches. However, whether these cells conveyed orally
acquired prions toward FDC within Peyer’s patches was not known. The chemokine
CXCL13 is expressed by FDC and follicular stromal cells and modulates the homing of
CXCR5-expressing cells toward the FDC-containing B cell follicles. Here, novel compound
transgenic mice were created in which a CXCR5 deﬁciency was speciﬁcally restricted to
CD11c cells. These mice were used to determine whether CXCR5-expressing conven-
tional dendritic cells propagate prions toward FDC after oral exposure. Our data show
that in the speciﬁc absence of CXCR5-expressing conventional dendritic cells the early
accumulation of prions upon FDC in Peyer’s patches and the spleen was impaired, and
disease susceptibility signiﬁcantly reduced. These data suggest that CXCR5-expressing
conventional dendritic cells play an important role in the efﬁcient propagation of orally
administered prions toward FDC within Peyer’s patches in order to establish host infec-
tion.
IMPORTANCE Many natural prion diseases are acquired by oral consumption of
contaminated food or pasture. Once the prions reach the brain they cause extensive
neurodegeneration, which ultimately leads to death. In order for the prions to efﬁ-
ciently spread from the gut to the brain, they ﬁrst replicate upon follicular dendritic
cells within intestinal Peyer’s patches. How the prions are ﬁrst delivered to follicular
dendritic cells to establish infection was unknown. Understanding this process is im-
portant since treatments which prevent prions from infecting follicular dendritic cells
can block their spread to the brain. We created mice in which mobile conventional
dendritic cells were unable to migrate toward follicular dendritic cells. In these mice
the early accumulation of prions on follicular dendritic cells was impaired and oral
prion disease susceptibility was reduced. This suggests that prions exploit conven-
tional dendritic cells to facilitate their initial delivery toward follicular dendritic cells
to establish host infection.
KEYWORDS prions, chemokines, intestine, dendritic cells, Peyer’s patches,
gastrointestinal infection, transmissible spongiform encephalopathy
Prion diseases, or transmissible spongiform encephalopathies (TSEs), are a uniquegroup of subacute neurodegenerative diseases that affect humans and some
domesticated and free-ranging animal species. Prion diseases are characterized by the
accumulation of aggregations of PrPSc, abnormally folded isoforms of the cellular prion
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protein (PrPC), in affected tissues. Prion infectivity copuriﬁes with PrPSc and constitutes
the major component of the infectious agent (1). Many prion diseases, including natural
sheep scrapie, bovine spongiform encephalopathy, chronic wasting disease in cervid
species, and kuru and variant Creutzfeldt-Jakob disease in humans, are acquired by
peripheral exposure, such as by oral consumption of prion-contaminated food or
pasture.
After ingestion many prion isolates initially accumulate and replicate ﬁrst upon
follicular dendritic cells (FDC) within the gut-associated lymphoid tissues (GALT) in the
small intestine, such as the Peyer’s patches, before they spread to the nervous system
(termed neuroinvasion) (2–9). After their replication upon FDC studies in experimental
rodents show that the prions subsequently infect neurons of both the sympathetic and
parasympathetic nervous systems and spread along these to the central nervous
system (CNS), where they ultimately cause neurodegeneration (10–12).
Mononuclear phagocytes arise from precursors in the bone marrow and comprise a
heterogeneous population of monocytes, conventional dendritic cells (DC), and tissue
macrophages. The different mononuclear phagocyte populations display a diverse
range of roles during prion disease (13). For example, tissue macrophages appear to aid
the sequestration and clearance of prions (14, 15), and microglia help protect the brain
against prion-induced neuropathology (16). Conventional DC are a distinct lineage
from the stromal derived FDC (17, 18) and are strategically located throughout the
body to sample the local environment for pathogens and their antigens. After antigen
uptake, these cells typically undergo a degree of maturation and migrate toward the
draining lymphoid tissue to initiate a speciﬁc immune response. Some conventional DC
populations can retain antigens in their native states and transfer them intact to naive
B cells in order to initiate a speciﬁc antibody response (19). The migratory character-
istics of conventional DC are exploited by some pathogens to facilitate their delivery to
lymphoid tissues (20–23). Independent studies have shown that the early replication of
prions upon FDC in the draining lymphoid tissue is impeded in the transient absence
of conventional DC at the time of exposure (24–27). This suggests that prions may also
exploit these cells to establish host infection after peripheral exposure, perhaps using
them as “Trojan horses.” Whether conventional DC propagate prions toward FDC within
the B cell follicles is not known. Treatments that prevent the uptake and propagation
of prions to FDC can signiﬁcantly delay disease pathogenesis and reduce susceptibility
(24–29). A thorough understanding of the cellular mechanisms used by prions to
establish infection upon FDC in the GALT may help to identify novel targets for
prophylactic intervention.
Chemokines attract lymphocytes and leukocytes to lymphoid tissues and control
their positioning within them. The chemokine CXCL13 is expressed by FDC and
follicular stromal cells in the B-cell follicles of lymphoid tissues and mediates the
homing of CXCR5-expressing cells toward them (30, 31). The migration of certain
populations of conventional DC toward the FDC-containing B-cell follicles is also
mediated by CXCL13-CXCR5 signaling (32–34). We therefore reasoned that if conven-
tional DC were important for the efﬁcient propagation of prions toward FDC in order
to establish host infection, this activity would be impeded and disease susceptibility
reduced in mice which speciﬁcally lacked CXCR5-expressing conventional DC. Since
mice that lack Peyer’s patches are refractory to oral prion infection (3, 5, 6, 35),
CXCR5/ mice and CXCL13/ mice were unsuitable for use here because they also
lack most Peyer’s patches and certain lymph nodes (31, 36). The few Peyer’s patches
that do develop in these mice are much smaller, and their microarchitecture is grossly
disturbed since the B cells are unable to form organized follicles (31, 36). Furthermore,
as a consequence of the disturbed microarchitecture in the spleens of CXCR5/ mice,
prion neuroinvasion after intraperitoneal exposure occurs at a higher rate because their
FDC are abnormally superimposed over sympathetic nerves (37). Therefore, in the
present study a unique compound transgenic mouse model was created in which Cxcr5
was speciﬁcally ablated in CD11c conventional DC. These CXCR5ΔDC mice were then
used to test the hypothesis that conventional DC play an important role in the efﬁcient
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propagation of prions toward FDC within the B cell follicles of Peyer’s patches after oral
exposure.
RESULTS
Conditional deletion of CXCR5 in CD11c cells. To enable conditional deletion of
Cxcr5 in speciﬁc cell populations without affecting the CXCL13-CXCR5-dependent
events required for normal lymphoid tissue development, mice with a conditional Cxcr5
allele were created by introducing loxP sites ﬂanking exon 2. Expression of Cre
recombinase under the control of the Itgax locus (which encodes CD11c) in CD11c-Cre
mice (38) has been used in many studies to conditionally delete the expression of target
genes in conventional DC (38–40). Homozygous CXCR5F/F mice were therefore cross-
bred to CD11c-Cre mice to generate mice speciﬁcally lacking CXCR5 expression in
CD11c conventional DC, termed CXCR5ΔDC mice here.
CD11c and CD11c cells were enriched from the spleens of CXCR5ΔDC mice. The
CD11c cells were further sorted based on their expression on CD11b, B220, and
CD90.2 to broadly represent tissue macrophages, B cells and T cells, respectively.
Reverse transcription-PCR (RT-PCR) analysis conﬁrmed the expression of Cre only in
mRNA derived from splenic CD11c cells (Fig. 1a). Further PCR analysis conﬁrmed
that in CXCR5ΔDC mice Cre recombinase-mediated recombination of the Cxcr5 allele
had only occurred in the genomic DNA of CD11c cells and was absent in each of
the CD11c cell populations studied (Fig. 1b). These data show that in CXCR5ΔDC
mice, Cre recombinase-mediated recombination of Cxcr5 is restricted to CD11c
conventional DC.
Conventional DC-speciﬁc CXCR5-deﬁciency does not affect secondary lym-
phoid tissue formation. Next, groups of CXCR5ΔDC mice and CXCR5F/F (control) mice
were injected intraperitoneally with Chicago Sky Blue 6B ink and analyzed 7 day later.
Over the exposure period, the dye becomes concentrated within secondary lymphoid
organs, enabling their macroscopic detection postmortem. The majority of the murine
secondary lymphoid tissues develop consistently, whereas the lumbar aortic lymph
nodes and lateral iliac lymph nodes are inconsistently present. As anticipated, the
incidence and frequency of the secondary lymphoid tissues in CXCR5F/F mice was
equivalent to those of nontransgenic wild-type mice (41). The secondary lymphoid
tissues in CXCR5ΔDC mice were also present at similar incidences and frequencies to
CXCR5F/F control mice (Table 1), unlike those in independently generated lines of
CXCR5/ mice and CXCL13/ mice (31, 36) (Table 2). These data show that a
conventional DC-restricted CXCR5 deﬁciency does not impact lymphoid tissue organo-
genesis.
Conventional DC from CXCR5DC mice have impaired chemotaxis toward
CXCL13. The chemokine CXCL13 is expressed by FDC and follicular stromal cells in the
FIG 1 Conditional deletion of Cxcr5 in CD11c cells. CD11c and CD11c cells were enriched from the
spleens of CXCR5ΔDC mice. The CD11c cells were further sorted based on their expression on CD11b,
B220, and CD90.2 to broadly represent tissue macrophages, B cells, and T cells, respectively. (a) RT-PCR
analysis conﬁrmed the expression of Cre only in mRNA derived from splenic CD11c cells. (b) Analysis of
genomic DNA conﬁrmed that Cre recombinase-mediated recombination of the Cxcr5 allele had only
occurred in CD11c cells, as demonstrated by presence of the lower Cxcr5de-ﬂox band. M, DNA size
markers; Spl, splenocytes; DC, CD11c conventional DC; Mac, CD11c macrophages; B, B cells; T, T cells.
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B-cell follicles of lymphoid tissues and mediates the homing of CXCR5-expressing cells
toward them (30, 31). Ex vivo chemotaxis assays conﬁrmed that the migration of
CD11c conventional DC from CXCR5ΔDC mice toward CXCL13 was signiﬁcantly im-
peded compared to conventional DC from CXCR5F/F control mice (Fig. 2; P  0.024). In
contrast, the chemotaxis of B cells (B220 cells) from CXCR5ΔDC mice toward CXCL13
TABLE 1 Comparison of the formation and frequency of secondary lymphoid tissues in
CXCR5ΔDC mice and CXCR5F/F (control) micea
Secondary lymphoid
tissueb
CXCR5F/F mice CXCR5DC mice
Incidence
No. present
(range) Incidence
No. present
(range)
Spleen 6/6 1 8/8 1
Mandibular LN 6/6 2 8/8 2
Accessory mandibular LN 6/6 2 8/8 2
Superﬁcial parotid LN 6/6 2 8/8 2
Cranial deep cervical LN 6/6 2 8/8 2
Proper axillary LN (brachial) 6/6 5 (4–6) 8/8 5 (4–6)
Accessory axillary LN 6/6 5 (2–7) 8/8 5 (3–6)
Subiliac LN (inguinal) 6/6 2 8/8 2
Sciatic LN 6/6 2 8/8 2
Popliteal LN 6/6 2 8/8 2
Cranial mediastinal LN 6/6 4 7/8 4
Tracheobronchial LN 6/6 1 8/8 1
Caudal mediastinal LN 6/6 1 8/8 1
Gastric LN 6/6 1 7/8 1 (0–1)
Pancreaticoduodenal LN 6/6 1 7/8 1 (0–1)
Jejunal LN (mesenteric) 6/6 5 (4–6) 8/8 5 (5–6)
Colic LN 5/6 1 (0–2) 7/8 1 (0–3)
Caudal mesenteric LN 6/6 1 8/8 1
Renal LN 6/6 2 (1–3) 8/8 2
Lumbar aortic LN* 4/6 2 (0–2) 1/8 1 (0–1)
Lateral iliac LN* 5/6 1 (0–1) 2/8 1 (0–1)
Medial iliac LN 6/6 2 (1–2) 8/8 2
External iliac LN 2/6 1 (0–1) 6/8 1 (0–1)
Peyer’s patches 6/6 6 (5–9) 8/8 6 (5–7)
Cecal patch (follicles) 6/6 5 (3–8) 7/8 2 (0–5)
a“Incidence” indicates the number of mice in which the tissue of interest was detectable/the number of mice
tested; “no. present (range)” indicates the number of tissues (minimum to maximum) detectable in each
mouse strain.
bLN, lymph nodes. *, Inconsistently present in wild-type mice.
TABLE 2 Comparison of secondary lymphoid tissue formation in CXCR5ΔDC mice, CXCR5F/F (control) mice, and independent lines of
CXCL13/ mice and CXCR5/ micea
Secondary lymphoid
tissue
Incidence
Present study Ansel et al. (31)b
CXCR5F/F
C57BL/6
cells
CXCR5DC
C57BL/6
cells CXCL13/ B6/129 cells CXCL13/ B6/129 cells CXCR5/ B6/129 cells CXCR5/ 129 cells
Superﬁcial parotid LN 6/6 8/8 47/47 42/46 5/5 9/10
Cranial deep cervical LN 6/6 8/8 14/16 1/14 0/5 0/10
Proper axillary (brachial) LN 6/6 8/8 42/42 1/42 2/5 0/10
Accessory axillary LN 6/6 8/8 42/42 1/42 0/5 0/10
Subiliac (inguinal) LN 6/6 8/8 41/41 0/41 0/5 0/10
Popliteal LN 6/6 8/8 15/19 0/18 0/5 10/10
Jejunal (mesenteric) LN 6/6 8/8 50/50 50/50 5/5 10/10
Renal LN 6/6 8/8 12/15 0/12 0/5 3/9
Medial iliac LN 6/6 8/8 38/38 0/41 0/5 0/10
Peyer’s patchesc 6/6 (6, 5–9) 8/8 (6, 5–7) 31/31 (2  3–6 29   6) 16/37 (21  0, 11 
1–2, 5  3–6)
4/5 (1  0, 2  1–2,
1  3–6, 1   6)
9/9 (5  1–2, 3 
3–6, 1   6)
aThe mouse strain background is speciﬁed in each column subheading. “Incidence” is expressed as the number of mice in which the tissue of interest was detectable/
the number of mice tested. LN, lymph nodes.
bData are derived from a study by Ansel et al. (31).
cThe “median number of Peyer=s patches/mouse, range” is indicated within parentheses for the present study. For the study by Ansel et al., the values indicate
“n  3–6”, where n is the number of mice with Peyer’s patches within the ranges indicated.
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was equivalent to that observed from cells from CXCR5F/F mice. The ability of conven-
tional DC to migrate toward the chemokine CCL21 (which signals via CCR7) was also
similar in cells from each mouse group.
Lymphoid tissue microarchitecture in CXCR5DC mice. The sampling of prions
across the intestinal epithelium by M cells, and their subsequent early replication upon
PrPC-expressing FDC is obligatory for efﬁcient neuroinvasion after oral exposure (4–6,
29, 42). We therefore determined whether the development of these cells was affected
in the lymphoid tissues of CXCR5ΔDC mice. Whole-mount immunostaining using the
mature M-cell marker glycoprotein 2 (GP2 [43, 44]) revealed similar densities of GP2
M cells in the follicle-associated epithelia (FAE) overlying the Peyer’s patches and
CXCR5ΔDC mice and CXCR5F/F control mice (Fig. 3A and B). The size of the FAE was also
equivalent (Fig. 3C). Unlike the disturbed distribution of FDC in the spleens of
CXCL13/ mice (37), those in the lymphoid tissues of CXCR5ΔDC mice formed distinct
networks. Furthermore, immunohistochemistry (IHC) and morphometric analysis sug-
gested that FDC size (the area occupied by CD35 immunostaining) was similar in the
mesenteric lymph nodes (MLN) and spleens from CXCR5ΔDC and CXCR5F/F mice (Fig. 3H
and K, respectively), although those in the Peyer’s patches of CXCR5ΔDC mice were
slightly smaller (Fig. 3E). However, the abundance of PrPC immunostaining upon FDC
in Peyer’s patches and MLN from each mouse group was similar (Fig. 3F and I,
respectively), although a marginal reduction was in observed in the spleens of
CXCR5ΔDC mice (Fig. 3L).
Prion accumulation in lymphoid tissues is reduced in orally exposed CXCR5DC
mice. In order to determine the effects of conventional DC-speciﬁc CXCR5-deﬁciency
on oral prion pathogenesis, groups of CXCR5ΔDC mice and CXCR5F/F mice were orally
exposed to ME7 scrapie prions and Peyer’s patches, MLN, and spleens collected at
intervals afterwards (n  4/group). Prion disease-speciﬁc, abnormal accumulations of
PrP (referred to as PrPd) characteristically present only in prion-affected tissues were
detected by IHC (4–6, 29, 45–48). Parafﬁn-embedded tissue (PET) blot analysis of
adjacent membrane-bound sections was used to conﬁrm that these PrPd aggregates
contained prion disease-speciﬁc, relatively proteinase K (PK)-resistant PrPSc (49).
As anticipated, by 70 days postinfection (dpi), abundant PrPSc accumulations were
detected in association with FDC (CD21/35 cells) in the majority of the Peyer’s patches
from CXCR5F/F control mice (Fig. 4A). By 105 dpi, heavy FDC-associated PrPSc accumu-
lations were detected in all the Peyer’s patches of CXCR5F/F mice (Fig. 4B and C).
However, the incidence of the PrPSc accumulation in Peyer’s patches of CXCR5ΔDC mice
was reduced at each of these times after prion exposure (Fig. 4A to C).
FIG 2 CD11c conventional DC from CXCR5ΔDC mice have impaired chemotaxis toward CXCL13. Ex
vivo chemotaxis of mesenteric lymph node (MLN) cells from CXCR5ΔDC mice and CXCR5F/F control
mice toward CXCL13 or CCL21 (200 ng/ml). The number of CD11c cells, CD3 lymphocytes (T cells)
and B220 lymphocytes (B cells) which had migrated into the lower chamber after 24 h was
determined by ﬂow cytometry. Med., medium alone was used as a control. The ability of CD11c
conventional DC from CXCR5ΔDC mice to migrate toward CXCL13 was signiﬁcantly impeded. *, P 
0.024 (n  5 wells/treatment).
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May 2017 Volume 91 Issue 10 e00124-17 jvi.asm.org 5
 o
n
 M
ay 5, 2017 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
Within weeks of oral exposure, high levels of ME7 scrapie prions ﬁrst accumulate
upon FDC in the Peyer’s patches and are subsequently disseminated via the blood and
lymph to most other lymphoid tissues (4–6, 24, 29, 50). In the spleens of orally exposed
CXCR5F/F control mice, some FDC-associated PrPSc accumulations were ﬁrst evident at
70 dpi (Fig. 5A to C). However, the abundance of these FDC-associated PrPSc accumu-
lations was reduced in the spleens of CXCR5ΔDC mice at 70 and 105 dpi (Fig. 5A to C).
To compare the prion infectivity levels within these tissues, spleen homogenates were
FIG 3 Comparison of M cell and follicular dendritic cell (FDC) status in the secondary lymphoid tissues of CXCR5ΔDC mice and
CXCR5F/F control mice. (A) Peyer’s patches were whole-mount immunostained to detect M cells (GP2 cells, green). F-actin
(blue) was used as a counterstain. The broken line indicates the boundary of the follicle associated epithelium (FAE). V, villi.
(B) The number of GP2 M cells/FAE was similar in Peyer’s patches from each mouse group (P  0.710). (C) Morphometric
analysis suggested the size of the FAE area was also similar in each mouse group (P 0.265 [Student t test]; data were derived
from 2 to 20 FAE/mouse [n  6 to 8 mice/group]). IHC comparisons of CD35 (magenta) and PrPC (green) expression by FDC
in the Peyer’s patches (D), mesenteric lymph nodes (MLN) (G), and spleens (J) of CXCR5F/F and CXCR5ΔDC mice are shown. The
sizes of the FDC in the Peyer’s patches (E), MLN (H), and (K) spleens of mice from each group were estimated by morphometric
analysis of the area of CD35 immunostaining. The abundance of PrPC expressed by the FDC in Peyer’s patches (F), MLN (I),
or spleens (L) from each mouse group was estimated by morphometric analysis of the number of PrPC pixels within each FDC
network. Data were derived from 2 to 10 FDC/mouse (n  6 to 8 mice/group).
Bradford et al. Journal of Virology
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prepared and injected intracerebrally (i.c.) into groups of tga20 indicator mice (n  4
recipient tga20 mice/spleen homogenate). High levels of prion infectivity were de-
tected in the majority of the spleens collected from the CXCR5F/F control mice at 70 dpi
and had increased in magnitude by 105 dpi (Fig. 5D). In contrast, signiﬁcantly lower
levels of prion infectivity were detected in the spleens of orally exposed CXCR5ΔDC mice
(Fig. 5D; 70 dpi, P  0.0004; 105 dpi, P  0.009; log-rank [Mantel-Cox] test). Only trace
levels of prion infectivity were detected in three of four spleens from the CXCR5ΔDC
mice analyzed at 70 dpi and in two of the four spleens analyzed at 105 dpi.
Together, these data show that in the speciﬁc absence of CXCR5-expressing con-
ventional DC at the time of oral exposure, the early accumulation of prions upon FDC
FIG 4 The early accumulation of prions in the Peyer’s patches is delayed in CXCR5ΔDC mice. Mice were orally
exposed to ME7 scrapie prions; Peyer’s patches were collected at 70 and 105 dpi and analyzed by IHC and
PET immunoblot analysis. At 70 (A) and 105 (B) dpi, the frequencies of FDC networks containing PrPSc in
the Peyer’s patches from each mouse group were compared (n  4 mice/group). Horizontal bar, median.
(C) IHC analysis showed that at 105 dpi, high levels of disease-speciﬁc PrP (PrPd; brown, middle row, arrows)
were detected in association with FDC (CD21/35 cells; brown, upper row) in Peyer’s patches from CXCR5F/F
control mice. Sections were counterstained with hematoxylin to detect cell nuclei (blue). Analysis of
adjacent sections by PET immunoblot analysis conﬁrmed the presence of prion-speciﬁc PK-resistant PrPSc
(blue/black). In contrast, although PrPSc was detectable in association with FDC in some of the tissues from
orally exposed CXCR5ΔDC mice (right-hand column), many FDC in the Peyer’s patches of CXCR5ΔDC mice
lacked PrPSc accumulation (middle column). Scale bar, 100 m.
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FIG 5 Comparison of prion accumulation in the spleens and MLN of orally exposed CXCR5F/F and CXCR5ΔDC
mice. Mice were orally exposed to ME7 scrapie prions, and spleens and MLN were collected at 70 and 105
dpi. At 70 (A) and 105 (B) dpi, the frequencies of FDC networks containing PrPSc in the spleens from
CXCR5ΔDC mice were reduced compared to CXCR5F/F control mice (n  4 mice/group). Horizontal bar,
median. (C) IHC analysis showed that at 105 dpi high levels of disease-speciﬁc PrP (PrPd; brown, middle row,
arrow) were detected in association with FDC (CD21/35 cells; brown, upper row) in spleens from CXCR5F/F
control mice. Sections were counterstained with hematoxylin to detect cell nuclei (blue). Analysis of
adjacent sections by PET immunoblot analysis conﬁrmed the presence of prion-speciﬁc PK-resistant PrPSc
(blue/black). In contrast, PrPSc was not detectable in association with the majority of the FDC in spleens
(Continued on next page)
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in the Peyer’s patches and spleen is signiﬁcantly delayed. However, abundant levels of
PrPSc were evident in association with FDC in the MLN of CXCR5ΔDC and CXCR5F/F mice
at each time point after oral exposure to ME7 scrapie prions (Fig. 5E to G). This implied
that the accumulation of prions upon FDC in the MLN was unaffected by an absence
of CXCR5-expressing conventional DC.
Oral prion disease susceptibility is reduced in the speciﬁc absence of CXCR5-
expressing conventional DC. Since oral exposure to a limiting dose of ME7 scrapie
prions typically yields a disease incidence of 100% in wild-type (control) mice, it was
used here to enable the effects of conventional DC-restricted CXCR5-deﬁciency on
survival time and prion disease susceptibility to be determined. As anticipated, the
majority of the orally exposed CXCR5F/F (control) mice succumbed to clinical prion
disease (Fig. 6A; mean, 376  12 days; median, 382 days; n  6/8). In contrast, disease
susceptibility was signiﬁcantly reduced in the orally exposed CXCR5ΔDC mice, since
only two of seven mice succumbed to clinical prion disease with individual survival
times of 343 and 371 days: the remaining ﬁve mice did not develop clinical signs of
prion disease up to at least 501 dpi (Fig. 6A; P  0.023 [Fisher exact test]). All of the
brains from the mice in each group that developed clinical signs of prion disease
had the characteristic spongiform pathology (vacuolation), disease-speciﬁc PrP
accumulation, astrogliosis, and microgliosis and typically associated with terminal
infection with ME7 scrapie prions (Fig. 6B and C). The distribution and severity of
the spongiform pathology was also similar in the brains of all the clinically affected
mice (Fig. 6D), indicating that conventional DC-speciﬁc CXCR5 deﬁciency did not
alter the course of CNS prion disease once neuroinvasion had occurred. No histo-
pathological signs of prion disease were detected in the brains of any of the
clinically negative mice.
After oral exposure, high levels of ME7 scrapie prions are maintained upon FDC in
lymphoid tissues until the terminal stages of disease (5, 6, 24, 29). Here, FDC-associated
PrPSc accumulations were detected in the Peyer’s patches, MLN, and spleens of all
clinically affected CXCR5ΔDC and CXCR5F/F mice (Fig. 7). In comparison, no evidence of
PrPSc accumulation was observed in any of the tissues from the clinically negative mice
(Fig. 7). These data indicate that all of the clinically negative mice were free of prions
in their lymphoid tissues and brains and were highly unlikely to succumb clinical prion
disease after substantially extended survival times. Together, these data show that
CXCR5-expressing conventional DC are essential for efﬁcient prion neuroinvasion after
oral exposure.
Conventional DC-speciﬁc CXCR5 deﬁciency does not inﬂuence prion disease
susceptibility when infection is established directly within the CNS. When groups
of CXCR5ΔDC and CXCR5F/F mice were injected i.c. with ME7 scrapie prions directly into
the CNS, all mice succumbed to clinical disease with similar survival times (CXCR5ΔDC
mice, 157  2 days, n  4/4; CXCR5ﬂ mice, 162  3 days, n  4/4; P  0.302).
Histopathological analysis of the brains from each group of clinically affected mice
revealed the characteristic neuropathology and PrPSc accumulation associated with
terminal infection with ME7 scrapie prions (Fig. 8A and B). The distribution and severity
of the spongiform pathology was also similar in the brains of the clinically affected
CXCR5ΔDC and CXCR5F/F mice (Fig. 8C). Therefore, a CXCR5 deﬁciency speciﬁcally in
FIG 5 Legend (Continued)
from orally exposed CXCR5ΔDC mice. (D) Prion infectivity levels were assayed in spleens from CXCR5F/F and
CXCR5ΔDC mice (n 4 spleens/group) collected at 70 and 105 dpi. Prion infectivity titers (log10 ID50/g tissue)
were determined by the injection of tissue homogenates into groups of tga20 indicator mice (n  4
recipient mice/spleen). Each symbol represents data derived from an individual spleen. Data below the
horizontal line indicate disease incidence in the recipient mice 100% and considered to contain trace
levels of prion infectivity. IHC and PET blot analysis suggested that the frequencies of FDC networks
containing PrPSc in the MLN of CXCR5ΔDC and CXCR5F/F control mice were similar at 70 (E) and 105 (F) dpi
(n 4 mice/group). (G) Analysis of adjacent sections showed that at 105 dpi high levels of PrPSc (blue/black,
upper row, arrows) were detected in association with FDC (CD21/35 cells; brown, low row) in MLN from
each mouse group. Sections were counterstained with hematoxylin to detect cell nuclei (blue).
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FIG 6 Oral prion disease susceptibility is reduced in CXCR5ΔDC mice. (A) Disease susceptibility after oral
exposure of CXCR5ΔDC (red) and CXCR5F/F control (blue) mice to a limiting dose of prions (P  0.023
[Fisher exact test]. (B) High levels of spongiform pathology (hematoxylin and eosin staining [H&E]), heavy
accumulations of disease-speciﬁc PrP, (PrPd; brown), reactive astrocytes expressing GFAP (brown), and
active microglia expressing IBA1 (brown) were detected in the brains of all orally exposed mice with
clinical prion disease. None of these histopathological signs of prion disease were detected in the brains
of any of the clinically negative mice up to at least 501 days after oral exposure. Clin., clinical prion
disease status; pos., clinically positive; neg., clinically negative; individual survival times are shown.
Sections were counterstained with hematoxylin to detect cell nuclei (blue). (C) Immunoblot analysis of
brain tissue homogenates conﬁrmed the presence of high levels of prion-speciﬁc, relatively PK-resistant
PrPSc within the brains of the clinically affected mice from each group. However, no PrPSc was detected
in the brains of any of the clinically negative CXCR5ΔDC mice. Samples were treated in the presence (lower
(Continued on next page)
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conventional DC did not affect prion disease pathogenesis or susceptibility when the
infection was established directly within the CNS. These data are consistent with the
independent observation that prion propagation within the CNS is not affected in
CXCR5/ mice (37).
FIG 7 Prion accumulation in the lymphoid tissues of CXCR5ΔDC and CXCR5F/F mice at the terminal stage of disease.
Mice were orally exposed to ME7 scrapie prions, and Peyer’s patches, MLN, and spleens were collected from all
clinically affected mice and from those free of clinical signs of prion disease at the end of the experiment at 501
dpi. Clin., clinical prion disease status; pos., clinically positive; neg. clinically negative. Individual survival times are
shown. High levels of PrPSc (PET immunoblot; black, arrows) were detected in association with follicular dendritic
cells (CD21/35 cells; brown, arrows) in the Peyer’s patches, MLN, and spleens from all clinically affected mice. In
contrast, no PrPSc was detected in tissues from any of the clinically negative survivors at 501 dpi. Sections were
counterstained with hematoxylin to detect cell nuclei (blue). CXCR5F/F Clin. pos, n 6 mice; CXCR5F/F Clin. neg, n
2 mice; CXCR5ΔDC Clin. pos, n  2 mice; CXCR5ΔDC Clin. neg, n  5 mice.
FIG 6 Legend (Continued)
panel) or absence (upper panel) of PK before electrophoresis. After PK treatment, a typical three-band
pattern was observed between molecular mass value of 20 to 30 kDa, representing unglycosylated, monogly-
cosylated, and diglycosylated isomers of PrP (in order of increasing molecular mass). (D) The severity and
distribution of the spongiform pathology (vacuolation) within each brain was scored on a scale of 1 to 5 in
nine gray-matter areas: G1, dorsal medulla; G2, cerebellar cortex; G3, superior colliculus; G4, hypothalamus; G5,
thalamus; G6, hippocampus; G7, septum; G8, retrosplenial and adjacent motor cortex; and G9, cingulate and
adjacent motor cortex. Each point represents the mean vacuolation score  SE.
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Splenectomy before oral prion exposure does not inﬂuence disease suscepti-
bility. The data presented above show that the early accumulation of prions in the
Peyer’s patches (Fig. 4) and spleens (Fig. 5) of orally exposed CXCR5ΔDC mice was
impaired. Although early prion replication upon FDC in the Peyer’s patches in the small
intestine is essential for efﬁcient neuroinvasion after oral exposure (5, 6, 45), we
considered it plausible that the effects observed here on disease susceptibility were
due to impaired neuroinvasion from the spleen. If the spleen did play an important role
in prion neuroinvasion after oral exposure, we reasoned that splenectomy before prion
exposure would similarly impede neuroinvasion and reduce disease susceptibility. To
test this hypothesis, wild-type mice were surgically splenectomized and 8 days later
orally exposed to a 0.1% dose of ME7 scrapie prions as described above. A parallel
group of mice were sham operated before oral prion exposure as a control. Our data
show that splenectomy did not inﬂuence prion disease pathogenesis or susceptibility
as mice from each treatment group succumbed to clinical disease with similar survival
times and disease incidences (Fig. 9A; splenectomized mice, mean  371  13 days,
median 364 days, n 6/11; sham-operated mice, mean 367 11 days, median 364
days, n  7/11 [P  1.0, Fisher exact test]). The distribution and severity of the
spongiform pathology were also similar in the brains of all the clinically affected
FIG 8 Neuropathological comparison of brains from clinically affected CXCR5ΔDC and CXCR5F/F mice after injection
of prion directly into the CNS. CXCR5ΔDC and CXCR5F/F mice (n  4/group) were injected i.c. with ME7 scrapie
prions, and brains were collected at the terminal stage of disease. (A) Histopathological analysis revealed the typical
spongiform pathology (H&E, top row), heavy accumulations of prion disease-speciﬁc PrPd (brown, second row),
reactive astrocytes expressing GFAP (brown, third row), and active microglia expressing IBA1 (brown, bottom row)
in the brains of all clinically affected mice from each group. Sections were counterstained with hematoxylin to
detect cell nuclei (blue). (B) Immunoblot analysis of brain tissue homogenates conﬁrmed the presence of high
levels of prion-speciﬁc, relatively PK-resistant PrPSc within the brains of mice from each group. Samples were
treated in the presence () or absence () of PK before electrophoresis. After PK treatment, a typical three-band
pattern was observed between molecular mass values of 20 to 30 kDa, representing unglycosylated, monoglyco-
sylated, and diglycosylated isomers of PrP (in order of increasing molecular mass). (C) The severity and distribution
of the spongiform pathology (vacuolation) within the brains of all clinically affected CXCR5ΔDC and CXCR5F/F mice
was similar. The severity of the vacuolation in each brain was scored on a scale of 1 to 5 in the following gray matter
regions: G1, dorsal medulla; G2, cerebellar cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6,
hippocampus; G7, septum; G8, retrosplenial and adjacent motor cortex; and G9, cingulate and adjacent motor
cortex. Each point represents the mean vacuolation score  the SE.
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splenectomized and sham-operated mice (Fig. 9B). These data clearly show that the
spleen does not play an important role in neuroinvasion after oral prion exposure. This
suggests that the major effects observed on oral prion disease pathogenesis and suscep-
tibility in CXCR5ΔDC mice were not due to impaired neuroinvasion from their spleens.
DISCUSSION
The early replication of prions upon FDC in Peyer’s patches is essential for efﬁcient
neuroinvasion from the small intestine after oral exposure (3–6, 35). The cellular
mechanism by which orally acquired prions are initially conveyed to FDC in order to
establish host infection was uncertain. Production of the chemokine CXCL13 by FDC
and follicular stromal cells plays an important role in attracting CXCR5-expressing cells
toward the FDC-containing B-cell follicles of secondary lymphoid organs (31, 36, 51).
Here, a unique compound transgenic mouse model was created in which CXCR5
deﬁciency was restricted to CD11c conventional DC. In the speciﬁc absence of
CXCR5-expressing conventional DC in CXCR5ΔDC mice, the early accumulation of prions
upon FDC in the Peyer’s patches and spleen was reduced, signiﬁcantly reducing disease
susceptibility. Our data suggest that CXCR5-expressing conventional DC are required
for the efﬁcient delivery of orally acquired prions to FDC in the Peyer’s patches of the
small intestine in order to achieve host infection.
The data presented here help advance our understanding of how orally acquired
prions utilize an elegant cellular relay to establish host infection from the lumen of the
small intestine. Prions are ﬁrst transported across the gut epithelium by M cells in the
FAE overlying the Peyer’s patches (29, 45, 52, 53). This initial transport of prions across
the gut epithelium by M cells is essential to establish infection in Peyer’s patches (29,
45). Antigens and particles that have been transported across the gut epithelium by M
cells are released into their underlying basolateral pockets where they are sampled by
FIG 9 Splenectomy before oral prion exposure does not inﬂuence disease susceptibility. C57BL/Dk
wild-type mice were surgically splenectomized, or sham operated (as a control), and 8 days later orally
exposed to a 0.1% dose of ME7 scrapie prions (n  11/group). (A) Comparison of disease susceptibility
of splenectomized (red) and sham-operated mice (blue) to oral prion infection (P  1.0 [Fisher exact
test]). (B) The severity and distribution of the spongiform pathology (vacuolation) within the brains of all
clinically affected splenectomized (open circles) and sham-operated mice (closed circles) was similar. The
severity of the vacuolation in each brain was scored on a scale of 1 to 5 in the following gray-matter
regions: G1, dorsal medulla; G2, cerebellar cortex; G3, superior colliculus; G4, hypothalamus; G5, thala-
mus; G6, hippocampus; G7, septum; G8, retrosplenial and adjacent motor cortex; and G9, cingulate and
adjacent motor cortex. Each point represents the mean vacuolation score  the SE.
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mononuclear phagocytes (54). Our data suggest that prions are subsequently acquired
by conventional DC (24, 55) and propagated by them in a CXCL13-CXCR5-dependent
manner toward FDC within the B-cell follicles of Peyer’s patches. The prions are then
acquired by FDC and ampliﬁed upon their surfaces above the threshold required to
achieve neuroinvasion (4–6, 42, 55). Studies from experimental mice indicate that
prions can establish infection in enteric nerves within 21 days after oral exposure (4, 55).
How the prions spread between the FDC and enteric nerves is not known, but a role for
conventional DC in this process has been proposed (56–58).
Whether these apparent prion propagation activities are restricted to certain con-
ventional DC populations is uncertain, but the speciﬁc depletion of CD8 CD11c cells
does not inﬂuence oral prion disease pathogenesis, implying that CD8 conventional
DC do not play a role (26). Indeed, within Peyer’s patches CD8 conventional DC are
rarely encountered within the subepithelial dome region immediately beneath the
M-cell-containing FAE. Instead, these cells are mostly localized within the T-cell-rich
interfollicular regions (59). Splenic plasmacytoid DC also accumulate high levels of
infectious prions during infection (60) but are unlikely to play a signiﬁcant role in prion
propagation since they do not migrate in the lymphatics during the steady state or
after activation (61).
Whether the initial uptake of prions by conventional DC involves a speciﬁc receptor
is uncertain. Most mononuclear phagocyte populations express cellular PrPC (62–64),
but the propagation of prions from peripheral exposure sites to FDC is not affected by
the absence of PrPC expression in hematopoietic cells (42, 48, 65–67). Conventional DC,
like the FDC in the B-cell follicles (28, 68–71), can acquire prions after their opsonization
by complement components such as C1q and C3 (72, 73). Depending on their location,
subset, and activation status, certain populations of conventional DC express a variety
of complement receptors (CR), including CR1 (CD35), CR2 (CD21), CR4 (CD11c/CD18),
calreticulin, CD93, and SIGN-R1 (CD209b), but it is uncertain whether they also facilitate
the complement-mediated uptake of prions by these cells (72, 73). However, SIGN-R1
is unlikely to play a role since its transient downregulation before prion exposure does
not inﬂuence disease pathogenesis (74). The possibility also cannot be excluded that
conventional DC simply acquire prions nonspeciﬁcally as they constitutively sample
their microenvironments via ﬂuid-phase micropinocytosis.
Although the data in the present study suggest that CXCR5-expressing conventional
DC are required for the efﬁcient propagation of prions to FDC in Peyer’s patches, it is
not known how they are transferred between these cell populations. Follicular B cells
within the subcapsular sinus of lymph nodes acquire lymph-borne immune complexes
via their CR and deliver them to FDC. The higher immune-complex-binding afﬁnity of
FDC appears to enable them to strip the B cells of their immune-complex cargo as they
migrate into the follicles (75–77). Conventional DC can retain PrPSc on both the cell
surface and in intracellular compartments (73). Since the expression level of CR1 and
CR2 on FDC is greater than the surrounding lymphocytes and leukocytes, it is plausible
that complement-opsonized prions are stripped from the surfaces of conventional DC
by FDC in a similar manner. Alternatively, it is plausible that conventional DC might
indirectly deliver infectious prions toward FDC. Since CR-expressing marginal zone B
cells in the spleen can shuttle complement-opsonized antigens to the FDC (78), B cells
may similarly strip opsonized prions from conventional DC in the vicinity of the B cell
follicle and deliver them to the FDC.
Tunneling nanotubes (TNT) are thin, membrane-bound cylinders of cytoplasm that
can connect neighboring cells to enable cell-to-cell communication and the intercel-
lular transfer of plasma membrane or cytoplasmic components. These TNT structures
are exploited by HIV-1 as a means of intercellular transfer between T cells (79) and to
shuttle virus-encoded immunosuppressive factors from infected macrophages to B cells
to suppress the humoral response (80). In vitro coculture studies suggest prions may
also transfer between conventional DC to neurons via endolysosomal vesicles within
TNT (57, 58, 81, 82). Infectious prions may also be released from infected cells in the
form of small endosome-derived vesicles termed exosomes (83) and, in doing so,
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enhance their ability to infect neighboring cells (60). Whether the transfer of prions
between conventional DC and FDC occurs in vivo via one or a combination of the above
processes remains to be determined.
We have previously shown that although the transient depletion of CD11c cells
impedes the accumulation of prions in Peyer’s patches and reduces disease suscepti-
bility, a small number of mice did develop clinical disease (24). In the present study, we
observed a similar effect on prion disease pathogenesis in the absence of CXCR5-
expressing conventional DC: prion accumulation was impeded in the Peyer’s patches
and spleens of orally exposed CXCR5ΔDC mice, and disease susceptibility was reduced,
but a small number of mice eventually succumbed to clinical prion disease. These
studies suggest that conventional DC provide an efﬁcient route by which prions are
initially conveyed to FDC. However, in their absence a limited amount of prions are able
to avoid clearance by cells such as tissues macrophages (14, 15) and reach the FDC via
alternative and less efﬁcient routes (27, 73, 84).
Studies in experimental mice show that after oral exposure, prions accumulate
ﬁrst in the Peyer’s patches in the small intestine and then spread via the blood and
lymph to most other secondary lymphoid tissues, including the spleen (4–6, 24, 50).
Analysis of the pathogenesis of natural sheep scrapie suggests a similar temporal
distribution (9). In the present study, the early accumulation of prions within the
MLN of CXCR5ΔDC mice was not impaired, suggesting that the prions had estab-
lished infection within the MLN independently of CXCR5-expressing conventional
DC. Although prions also replicate upon FDC in the MLN soon after oral exposure,
our studies in mice have shown that the MLN do not inﬂuence prion neuroinvasion
from the intestine (5, 6, 45).
We also showed that early prion replication in the spleens of CXCR5ΔDC mice was
signiﬁcantly reduced. This raised the possibility that the signiﬁcantly reduced prion
disease susceptibility observed in these mice was, at least in part, due to impaired
neuroinvasion from their spleens. However, splenectomy of conventional mice prior to
oral exposure with ME7 scrapie prions did not inﬂuence survival times or disease
susceptibility. These data are consistent with an earlier study using mouse-passaged
139A scrapie prions which also suggested that the spleen does not play a role in prion
disease pathogenesis after intragastric exposure (85), and our subsequent demonstra-
tions that the GALT in the small intestine are the important sites of early prion
accumulation and neuroinvasion after oral exposure (5, 6).
Many studies have deﬁned conventional DC based on their expression of distinct
cell surface markers such as the integrin CD11c. Murine conventional DC express CD11c
highly, and this has been used as a reliable marker for these cells in a wide range of
studies. However, the expression of this integrin is not restricted to conventional DC
since certain macrophage populations and activated monocytes can also express
CD11c to some degree (86, 87). The recent discovery that expression of the zinc ﬁnger
transcription factor ZBTB46 is restricted to conventional DC (88, 89) provides an
excellent opportunity to create conditional knockout mouse models to further deﬁne
the separate roles of conventional DC and tissue macrophages in prion disease
pathogenesis (90).
In conclusion, our data demonstrate that prions exploit conventional DC in order to
facilitate their efﬁcient propagation to FDC in Peyer’s patches in order to establish host
infection. The status of conventional DC is dramatically inﬂuenced by microbial stimuli
and inﬂammatory conditions in the intestine and can enhance the uptake of certain
pathogens from the gut lumen (91–93). Treatments that prevent the initial uptake and
accumulation of prions in Peyer’s patches can signiﬁcantly reduce disease susceptibility
(4, 24, 29). Therefore, a thorough understanding of the cellular and molecular mecha-
nisms which prions exploit to establish infection upon FDC in the GALT may help to
identify important factors that inﬂuence disease susceptibility or novel targets for
prophylactic intervention.
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MATERIALS AND METHODS
Mice. The following mouse strains were used in this study where indicated: CD11c-Cre (38); and
tga20, which overexpress PrPC (94). Cxcr5F/F mice were produced by Ozgene (Bentley DC, Australia) and
created by introducing loxP sites ﬂanking exon 2 of the Cxcr5 gene via homologous recombination. All
mice were bred and maintained on a C57BL/6J mice background and maintained under speciﬁc-
pathogen-free conditions. In some studies C57BL/Dk mice were also used, where indicated. All studies
and regulatory licenses were approved by University of Edinburgh’s ethics committee and carried out
under the authority of a UK Home Ofﬁce Project License.
Genotype conﬁrmation by PCR analysis. CD11c cells were positively enriched from spleens by
magnetic antibody cell sorting using CD11c microbeads according to the manufacturer’s instructions
(Miltenyi Biotec, Bisley, UK). The cells in the CD11c ﬂowthrough fraction were further sorted using
CD11b microbeads to enrich monocytes/macrophages, CD45R (B220) microbeads to enrich B cells, and
CD90.2 microbeads to enrich T cells. DNA was extracted from each cell populations using a DNeasy blood
and tissue kit (Qiagen, Crawley, UK) according to the manufacturer’s instructions. RNA was extracted
using RNA-Bee (AMS Biotechnology, Abingdon, UK), and cDNA was synthesized using a Superscript
ﬁrst-strand synthesis kit (Invitrogen). Where indicated, genomic or cDNA samples were analyzed for the
presence of Cre, Cxcr5F, and recombined Cxcr5F (Cxcr5de-ﬂox) using the following primers: Cre (5=-CGAG
TGATGAGGTTCGCAAGAACC-3= and 5=-GCTAAGTGCCTTCTCTACACCTGC-3=) and Cxcr5F and recombined
Cxcr5ﬂox (Cxcr5de-ﬂox; 5=-AGGAGGCCATTTCCTCAGTT-3=, 5=-GGCTTAGGGATTGCAGTCAG-3=, and 5=-TTCCT
TAGAGCCTGGAAAAGG-3=).
Macroscopic analysis of secondary lymphoid tissues. Mice were injected intraperitoneally with
300 l of 1% Chicago Sky Blue 6B in sterile phosphate-buffered saline. Mice were culled 7 days later, and
the presence or absence of secondary lymphoid organs was determined macroscopically (41).
Chemotaxis assays. Ex vivo chemotaxis assays were performed as described previously (33, 95).
Brieﬂy, MLN cells in RPMI medium with 5% fetal calf serum (Invitrogen) were placed in the upper
chamber of a 5-m Transwell insert in a 24-well plate (Corning, Corning, NY). The lower chamber
contained 200 ng of either CXCL13 or CCL21 (Peprotech, London, UK)/ml. Five technical replicates were
performed. After 24 h, the upper chamber was discarded, and the cells in the lower chamber were
collected and immunostained with anti-CD3 (clone 17A2) to detect T cells, anti-B220 (clone RA3-2GB) to
detect B cells, and anti-CD11c (clone N418; BioLegend, London, UK) and resuspended in 500 l of
ﬂuorescence-activated cell sorting buffer. The number of migrated cells was counted for 60 s using a
LSRFortessa ﬂow cytometer (BD Biosciences).
Prion exposure and disease monitoring. For oral exposure, mice were fed individual food pellets
dosed with 50 l of a 0.1% (wt/vol) dilution of scrapie brain homogenate (containing approximately
2.5  103 i.c. 50% infectious dose [ID50] units) prepared from mice terminally affected with ME7 scrapie
prions according to our standard protocol (4–6, 24, 29, 96). During the dosing period mice were
individually housed in bedding- and food-free cages with water provided ad libitum. A single prion-
dosed food pellet was then placed in the cage. The mice were returned to their original cages (with
bedding and food ad libitum) as soon as the food pellet was observed to have been completely ingested.
The use of bedding- and additional food-free cages ensured easy monitoring of consumption of the
prion-contaminated food pellet. For i.c. exposure, mice were injected with 20 l of a 1% dilution of
scrapie brain homogenate. After prion exposure, mice were coded and assessed weekly for signs of
clinical disease and culled at a standard clinical endpoint. The clinical endpoint of disease was deter-
mined by rating the severity of clinical signs of prion disease exhibited by the mice. The mice were
clinically scored as “unaffected,” “possibly affected,” or “deﬁnitely affected” according to standard criteria
that typically present in mice with terminal ME7 scrapie prion disease. Clinical signs following infection
with the ME7 scrapie agent may include weight-loss, starry coat, hunched and jumpy behavior (at early
onset) progressing to limited movement, upright tail, wet genitals, decreased awareness, discharge from
eyes and/or blinking eyes, and ataxia of the hind legs. The clinical endpoint of disease was deﬁned in one
of the following ways: (i) the day on which a mouse received a second consecutive “deﬁnite” rating, (ii)
the day on which a mouse received a third “deﬁnite” rating within four consecutive weeks, or (iii) the day
on which a mouse was culled in extremis. Survival times were recorded for mice that did not develop
clinical signs of disease during the observation period. Prion diagnosis was conﬁrmed by histopatho-
logical assessment of vacuolation in the brain. For the construction of lesion proﬁles, vacuolar changes
were scored in nine distinct gray-matter regions of the brain, as described previously (97).
For bioassay of prion infectivity, individual spleens were prepared as 1% (wt/vol) homogenates. For
each tissue homogenate, groups of tga20 indicator mice (n  4/homogenate) were injected i.c. with
20 l of homogenate. The prion infectivity titer in each sample was determined from the mean
incubation period in the indicator mice by reference to a dose/incubation period response curve for ME7
scrapie-infected spleen tissue serially titrated in tga20 mice using the following relationship: y  9.4533
to 0.0595x (where y is the log ID50 U/20 l of homogenate, and x is the incubation period [R2  0.9562]).
Since the expression level of cellular PrPC controls the prion disease incubation period, tga20 mice
overexpressing PrPC are extremely useful as indicator mice in scrapie agent infectivity bioassays because
they succumb to disease with much shorter incubation times than conventional mouse strains (94).
Splenectomy. Groups of C57BL/Dk mice were surgically splenectomized and orally exposed to
prions 8 days later. Brieﬂy, an	1-cm incision was made in the left upper quadrant of the abdominal wall,
and the spleen was identiﬁed. Blood supply to the organ was tied off with sutures before removal. The
incision site was then also closed with sutures. Isoﬂurane anesthesia was used throughout the surgical
procedure. After surgery, the mice were closely monitored throughout the recovery period and given
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buprenorphine hydrochloride as an analgesic. Sham-operated mice (laparotomy incision and suture
repair with no spleen removal) were used as a control.
IHC and immunoﬂuorescent analyses.Whole-mount immunostaining was performed as previously
described (29). Brieﬂy, Peyer’s patches were ﬁxed with BD Cytoﬁx/Cytoperm (BD Biosciences, Oxford, UK),
and subsequently immunostained with rat anti-mouse GP2 monoclonal antibody (MAb; MBL Interna-
tional, Woburn, MA). After the addition of primary antibody, the tissues were stained with Alexa Fluor
488-conjugated anti-rat IgG antibody (Invitrogen, Paisley, UK) and Alexa Fluor 647-conjugated phalloidin
to detect f-actin (Invitrogen).
Intestines, MLN, and spleens were also removed and snap-frozen at the temperature of liquid
nitrogen. Serial frozen sections (6 m in thickness) were cut on a cryostat and immunostained with the
following antibodies: FDC were visualized by staining with MAb 8C12 to detect CR1 (CD35; BD
Biosciences) and cellular PrPC was detected using PrP-speciﬁc polyclonal antibody (pAb) 1B3 (98). Where
appropriate, sections were counterstained with DAPI (4=,6=-diamidino-2-phenylindole) to detect cell
nuclei (Life Technologies).
For the detection of disease-speciﬁc PrP (PrPd) in intestines, MLN, spleens, and brains, tissues were
ﬁxed in periodate-lysine-paraformaldehyde ﬁxative and embedded in parafﬁn wax. Sections (thickness,
6 m) were deparafﬁnized and pretreated to enhance the detection of PrPd by hydrated autoclaving (15
min, 121°C, hydration) and subsequent immersion in formic acid (98%) for 5 min. The sections were then
immunostained with 1B3 PrP-speciﬁc pAb. For the detection of astrocytes, brain sections were immu-
nostained with anti-glial ﬁbrillary acidic protein (GFAP; Dako, Ely, UK). For the detection of microglia,
deparafﬁnized brain sections were ﬁrst pretreated with citrate buffer and subsequently immunostained
with anti-ionized calcium-binding adaptor molecule 1 (Iba-1; Wako Chemicals GmbH, Neuss, Germany).
For the detection of FDC in intestines, MLN, and spleens, deparafﬁnized sections were ﬁrst pretreated
with Target Retrieval Solution (Dako) and then immunostained with anti-CD21/35 (clone 7G6; BD
Biosciences). PET immunoblot analysis was used to conﬁrm the PrPd detected by IHC was proteinase
K-resistant PrPSc (49). Membranes were subsequently immunostained with 1B3 PrP-speciﬁc pAb.
For light microscopy, following the addition of primary antibodies, biotin-conjugated species-speciﬁc
secondary antibodies (Stratech, Soham, UK) were applied, and immunolabeling was revealed using
horseradish peroxidase-conjugated avidin-biotin complex (ABC kit; Vector Laboratories, Peterborough,
United Kingdom) and visualized with DAB (diaminobenzidine; Sigma). Sections were counterstained with
hematoxylin to distinguish cell nuclei. For ﬂuorescence microscopy, following the addition of primary
antibody, streptavidin-conjugated or species-speciﬁc secondary antibodies coupled to Alexa Fluor 488
(green), Alexa Fluor 594 (red), or Alexa Fluor 647 (blue) dyes (Life Technologies) were used. The sections
were subsequently mounted in ﬂuorescent mounting medium (Dako). Images of whole-mount immu-
nostained intestinal pieces and cryosections were obtained using a Zeiss LSM710 confocal microscope
(Zeiss, Welwyn Garden City, UK).
Image analysis. For morphometric analysis, images were analyzed using ImageJ software (http://
rsb.info.nih.gov/ij/) as described on coded sections (42, 45, 99). Background intensity thresholds were ﬁrst
applied using an ImageJ macro which measures pixel intensity across all immunostained and nonstained
areas of the images. The obtained pixel intensity threshold value was then applied in all subsequent
analyses. Next, the number of pixels of each color (black, red, green, yellow, etc.) were automatically
counted. For these analyses, data are presented as the proportion of positively stained pixels for a given
IHC marker per total number of pixels (all colors) in the speciﬁc area of interest. In each instance, typically
six images were analyzed per mouse, from tissues from multiple mice per group (n 6 to 8 mice/group).
Details for all of the sample sizes for each parameter analyzed are provided in the ﬁgure legends.
Immunoblot detection of PrPSc. Brain homogenates (10% weight/volume) were prepared in NP-40
lysis buffer (1% NP-40, 0.5% sodium deoxycholate, 150 mM NaCl, 50 mM Tris-HCl [pH 7.5]) and incubated
at 37°C for 1 h with proteinase K (PK) at 20 g/ml. Digestions were halted by addition of 1 mM
phenylmethylsulfonyl ﬂuoride. Samples were then subjected to electrophoresis through 12% Tris-glycine
polyacrylamide gels (Nupage; Life Technologies) and transferred to polyvinylidene diﬂuoride membranes
by semidry blotting. PrP was detected using anti-mouse PrP-speciﬁc MAb 7A12 (100), followed by
horseradish peroxidase-conjugated goat anti-mouse antibody (Jackson ImmunoResearch) and visualized
chemiluminescence (BM chemiluminescent substrate kit; Roche, Burgess Hill, UK).
Statistical analyses. Unless indicated otherwise, data are presented as means  the standard errors
(SE), and signiﬁcant differences between samples in different groups were evaluated by Student t test.
In instances where there was evidence of nonnormality, data were analyzed by nonparametric analysis
of variance (Kruskal-Wallis test) with Dunn’s multiple comparison post hoc test. P values of 0.05 were
accepted as signiﬁcant.
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